| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net income | -0.1 | -0.0 |
| EPS (diluted, $ a share) | $-0.00 | $-0.00 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Ctt Pharmaceutical Holdings, Inc.: key numbers
- Share price
- $0.0559Close, Nov 16
- Market cap
- $3.34M
- Shares outstanding
- 59.72MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Ctt Pharmaceutical Holdings, Inc.
All →Ctt Pharmaceutical Holdings Other 8-K Filing
CTT Pharmaceutical Holdings, Inc. has appointed Zhanna Kelley, CPA as its new PCAOB Auditor effective October 27, 2026. This follows the resignation of the company's previous auditor, Holt & Patterson, which was not due to any disagreements regarding accounting practices.
- Counterparty
- Zhanna Kelley, CPA
Ctt Pharmaceutical Holdings Leadership Change
CTT Pharmaceutical Holdings, Inc. has appointed Karen Larson as an Independent Board Member. Mrs. Larson brings extensive experience as a Certified Financial Planner and former investment banker at Chase Manhattan Bank, as well as entrepreneurial experience from founding a business sold to Morningstar.
- Counterparty
- Karen Larson